Reach Us +1-504-608-2390
Strengthening Pipeline Development Through Innovative Licensing Collaborations | 3289
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Strengthening pipeline development through innovative licensing collaborations

Gavin Zealey

: J Vaccines Vaccin

Collaborations, partnerships and licenses to new products and technologies are core to the Sanofi pasteur vaccine pipeline. There are many possible deal structures (acquisitions/options/licenses\fee-for-service) to accommodate the needs of a variety of partners. Critical issues for the establishment and success of partnerships will be described to strengthen pipelines through innovative licensing.
Dr Gavin Zealey is Senior Director, Corporate Development at Sanofi pasteur. Sanofi pasteur is the vaccines business of the pharmaceutical company Sanofi and is a world leader in human vaccines. Dr Zealey identifies opportunities for global licensing and acquisition of technologies used in the development of new products. He provides strategic and tactical evaluation of new business opportunities for vaccine product development, business partnerships, their technologies and alternatives to commercial relationships. He has negotiated many agreements, creating and managing commercial relationships. He has a Ph.D. an MBA from the Kellogg School of Management, is registered to practice before the Canadian and US Patent Offices and is a Certified Licensing Professional.